Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 1, 1998, Pages 101-105

  Pieper, Galen M ^a,b   Siebeneich, Wolfgang ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

Diabetes mellitus; Endothelium; Hydroxyl radical; N Acetylcysteine; Nitric oxide; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HYDROXYL RADICAL; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; HYPERGLYCEMIA; LONG TERM CARE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VASCULAR ENDOTHELIUM;

ACETYLCYSTEINE; ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; FREE RADICAL SCAVENGERS; MALE; NOREPINEPHRINE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031800116     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199807000-00016     Document Type: Article

References (35)

1. Pieper GM, Gross GJ. Endothelial dysfunction in diabetes. In: Rubanyi GM, ed. Cardiovascular significance of endothelium-derived vasoactive factors. Mount Kisco, NY: Futura Publishing, 1991:223-49.
2. Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation 1993;87 Suppl V:V67-76.
3. Kamata K, Miyata N, Abirut T, Kasuya Y. Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus. Life Sci 1995;50:1379-87.
4. Poston L, Taylor PD. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin Sci 1995;88:245-55.
5. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510-6.
6. McVeigh GE, Brennan GM, Johnston GD, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35: 771-6.
7. Hattori Y, Kawasaki H, Abe K, Kanno M. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 1991;261 (Heart Circ Physiol 30):H1086-94.
8. Langenstroer P, Pieper GM. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol 1992;263 (Heart Circ Physiol 32):H257-65.
9. Pieper GM, Mei DA, Langenstroer P, O'Rourke ST. Bioassay of endothelium-derived relaxing factor in diabetic rat aorta. Am J Physiol 1992;263(Heart Circ Physiol 32):H676-80.
10. Tesfamariam B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 1992; 263(Heart Circ Physiol 32):H321-6.
11. Diederich D, Skopec J, Diederich A, Dai FX. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol 1994;266(Heart Circ Physiol 35):H1153-61.
12. Rösen P, Ballhausen T, Bloch W, Addicks K. Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia 1995;38:1157-68.
13. Pieper GM, Moore-Hilton G, Roza AM. Evaluation of the mechanism of endothelial dysfunction in the genetically-diabetic BB rat. Life Sci 1996;58:PL147-52.
14. Pieper GM, Langenstroer P, Siebeneich W. Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res 1997;34:145-56.
15. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996;97:22-8.
16. Pieper GM, Siebeneich W, Roza AM, Jordan M, Adams MB. Chronic treatment in vivo with dimethylthiourea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol 1996;28:27-31.
17. Lammi-Keefe CJ, Swan PB, Hegarty PVJ. Evidence for increased peroxidative activity in muscles from streptozotocin-diabetic rats. Proc Soc Exp Biol Med 1984;176:27-31.
18. Wohaieb SA, Godin DV. Starvation-related alteration in free radical tissue defense mechanisms in rats. Diabetes 1987;36:169-73.
19. Hida W, Shindoh C, Satoh J, et al. N-Acetylcysteine inhibits loss of diaphragm function in streptozotocin-treated rats. Am J Respir Crit Care Med 1996;153:1875-9.
20. Sagara M, Satoh J, Wada R, et al. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine. Diabetologia 1996;39:263-9.
21. Keegan A, Walbank H, Cotter MA, Cameron NE. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia 1995;38:1475-8.
22. Pieper GM. Oxidative stress in diabetic blood vessels [Abstract]. FASEB J 1995;9:A891.
23. Ohkuwa T, Sato Y, Naoi M. Hydroxyl radical formation in diabetic rats induced by streptozotocin. Life Sci 1995;56:1789-98.
24. Bravenboer B, Kappelle AC, Hamers FPT, van Buren T, Erkelens DW, Gispen WH. Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia 1992;35:813-7.
25. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989;6:593-7.
26. Ghiselli A, Laurenti O, De Mattia G, Maiani G, Ferro-Luzzi A. Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients. Free Radic Biol Med 1992;13:621-6.
27. Pieper GM, Siebeneich W. Diabetes-induced endothelial dysfunction is prevented by chronic treatment with the modified iron chelator, hydroxyethyl starch-conjugated deferoxamine. J Cardiovasc Pharmacol 1997;30:734-8.
28. Pieper GM, Dondlinger L. Glucose elevations alter bradykinin-stimulated intracellular calcium accumulation in cultured endothelial cells. Cardiovasc Res 1997;34:169-78.
29. Pieper GM, Dondlinger L. Increases in extracellular glucose diminish bradykinin-stimulated intracellular calcium accumulation in cultured endothelial cells via an intracellular redox-sensitive pathway. Circulation 1996;94 Suppl I:I-41.
30. Huby R, Harding JJ. Nonenzymatic glycosylation (glycation) of lens proteins by galactose and protection by aspirin and reduced glutathione. Exp Eye Res 1988;47:53-9.
31. Wolff SP, Jiany ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 1991;10: 339-52.
32. Redmon JB, Pyzdrowski KL, Robertson RP. No effect of deferoxamine therapy on glucose homeostasis and insulin secretion in individuals with NIDDM and elevated serum ferritin. Diabetes 1993;42:544-9.
33. Angulo J, Sánchez-Ferrer CP, Peiró C, Marín J, Rodríquez-Mañas L. Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated human hemoglobin: possible mechanisms involved. Hypertension 1996;28:583-92.
34. Oltman CL, Gutterman DD, Scott EC, Bocker JM, Dellsperger KC. Effects of glycosylated hemoglobin on vascular responses in vitro. Cardiovasc Res 1997;34:179-84.
35. Bucala R, Tracey K, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 1991;87: 432-8.